Bessor Pharma

scientific-business

Scientific Advisors

Anthony Day, PhD
Professor of Biochemistry, Division of Cell Matrix Biology and Regenerative Medicine, Wellcome Trust Centre for Cell Matrix Research, University of Manchester (UK)
Armand Keating, MD FRCP(C)
Director, Cell Therapy Program and Philip S. Orsino Facility for Cell Therapy, Princess Margaret Hospital/Ontario Cancer Institute; Professor of Medicine, Professor, Institute of Biomaterials and Biomedical Engineering, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation, University of Toronto
Darwin Prockop, MD, PhD
Professor and Director, Institute for Regenerative Medicine, Professor of Molecular and Cellular Medicine and the Stearman Chair in Genomic Medicine, Texas A&M; Member National Academy of Sciences and National Institute of Medicines

Business Advisory Board

Marc E. Goldberg
Board of Directors; Chairman, Business Advisory Board
Co-founder and Managing Director, BioVentures Investors; former CEO Mass Biotech Research Institute, Founding President Mass Biotech Council (MassBio)
Richard L. Sherman
Former Deputy General Counsel, SmithKline Beckman
Jon Soderstrom, PhD
Board of Directors
Managing Director of the Office of Cooperative Research, Yale University